Dexcom Inc (NASDAQ: DXCM) is 10.02% higher on its value in year-to-date trading and has touched a low of $74.75 and a high of $142.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DXCM stock was last observed hovering at around $134.56 in the last trading session, with the day’s gains setting it 1.96%.
Currently trading at $136.52, the stock is -0.45% and 6.20% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.02 million and changing 1.46% at the moment leaves the stock 18.83% off its SMA200. DXCM registered 17.99% gain for a year compared to 6-month gain of 79.18%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 4.65% loss in the last 1 month and extending the period to 3 months gives it a 9.69%, and is -2.80% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.80% over the week and 2.94% over the month.
Dexcom Inc (DXCM) has around 9600 employees, a market worth around $52.63B and $3.62B in sales. Current P/E ratio is 104.16 and Fwd P/E is 61.02. Profit margin for the company is 14.95%. Distance from 52-week low is 82.64% and -3.86% from its 52-week high. The company has generated returns on investments over the last 12 months (11.67%).
The EPS is expected to grow by 15.91% this year.
Dexcom Inc (DXCM) Top Institutional Holders
The shares outstanding are 385.40M, and float is at 377.37M with Short Float at 3.86%.
Dexcom Inc (DXCM) Insider Activity
The most recent transaction is an insider sale by Dolan Matthew Vincent,the company’sEVP Strategy and Corporate Dev. SEC filings show that Dolan Matthew Vincent sold 1,990 shares of the company’s common stock on Apr 15 ’24 at a price of $137.81 per share for a total of $0.27 million. Following the sale, the insider now owns 42377.0 shares.
Dexcom Inc disclosed in a document filed with the SEC on Apr 08 ’24 that SAYER KEVIN R (President CEO and Chairman) sold a total of 49,633 shares of the company’s common stock. The trade occurred on Apr 08 ’24 and was made at $138.30 per share for $6.86 million. Following the transaction, the insider now directly holds 0.28 million shares of the DXCM stock.
Still, SEC filings show that on Mar 28 ’24, Brown Michael Jon (EVP Chief Legal Officer) disposed off 2,624 shares at an average price of $140.04 for $0.37 million. The insider now directly holds 68,682 shares of Dexcom Inc (DXCM).
